- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular carcinoma
Authors
Keywords
-
Journal
LANCET
Volume 400, Issue 10360, Pages 1345-1362
Publisher
Elsevier BV
Online
2022-09-07
DOI
10.1016/s0140-6736(22)01200-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
- (2022) Josep M. Llovet et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Dynamic risk profiling of hepatocellular carcinoma recurrence after curative intent liver resection
- (2022) Tommy Ivanics et al. HEPATOLOGY
- Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
- (2022) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Global, regional, and national cancer deaths and disability‐adjusted life‐years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990‐2019
- (2022) Saeid Safiri et al. CANCER
- Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
- (2022) Nick Freemantle et al. EUROPEAN JOURNAL OF CANCER
- Burden of Disease Associated with Dietary Exposure to Aflatoxins in China in 2020
- (2022) Tingting Chen et al. Nutrients
- Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
- (2022) Ahmed Omar Kaseb et al. Lancet Gastroenterology & Hepatology
- Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
- (2022) Thomas U Marron et al. Lancet Gastroenterology & Hepatology
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis
- (2021) Pankaj Gupta et al. EUROPEAN RADIOLOGY
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combined hepatocellular-cholangiocarcinoma: An update
- (2021) Aurélie Beaufrère et al. JOURNAL OF HEPATOLOGY
- Long-term Effectiveness of Population-wide Multifaceted Interventions for Hepatocellular Carcinoma in Taiwan
- (2021) Sih-Han Liao et al. JOURNAL OF HEPATOLOGY
- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015
- (2021) Jing Sun et al. JAMA Network Open
- Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
- (2021) Victor Sapena et al. GUT
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
- (2021) Roser Pinyol et al. JOURNAL OF HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
- (2021) Karim J. Halazun et al. JAMA Surgery
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
- (2021) Masatoshi Kudo et al. Liver Cancer
- Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis
- (2021) Giovanni Marasco et al. Journal of Clinical Medicine
- LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
- (2021) Alexa Childs et al. BRITISH JOURNAL OF CANCER
- The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study
- (2021) Philip J. Johnson et al. BRITISH JOURNAL OF CANCER
- Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: a meta-analysis
- (2021) Huimei Zhang et al. Future Oncology
- Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant
- (2021) Tiffany Cho‐Lam Wong et al. HEPATOLOGY
- A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival.
- (2021) Masatoshi Kudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Rational screening approaches for HCC in NAFLD patients
- (2021) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
- (2021) Masatoshi Kudo et al. JOURNAL OF HEPATOLOGY
- Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States
- (2021) Hyun-seok Kim et al. JOURNAL OF HEPATOLOGY
- Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
- (2021) Mihir D. Shanker et al. Journal of Medical Imaging and Radiation Oncology
- Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
- (2021) Peter R Galle et al. LANCET ONCOLOGY
- EGFR activation limits the response of liver cancer to lenvatinib
- (2021) Haojie Jin et al. NATURE
- Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant
- (2021) Quirino Lai et al. JAMA Surgery
- Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma
- (2021) Arndt Vogel et al. Liver Cancer
- Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial
- (2021) Arndt Vogel et al. Lancet Gastroenterology & Hepatology
- Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies
- (2021) Masatoshi Kudo et al. CLINICAL CANCER RESEARCH
- An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
- (2021) Hwi Young Kim et al. JOURNAL OF HEPATOLOGY
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
- (2021) Bernhard Scheiner et al. JOURNAL OF HEPATOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center
- (2021) Tommy Ivanics et al. SURGERY
- Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma
- (2021) Lorenza Rimassa et al. Liver Cancer
- Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial
- (2021) David Tai et al. Lancet Gastroenterology & Hepatology
- External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
- (2021) Smith Apisarnthanarax et al. Practical Radiation Oncology
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
- (2020) L.-T. Chen et al. ANNALS OF ONCOLOGY
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
- (2020) Jérôme Durand-Labrunie et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: a Systematic Review and Meta-analysis
- (2020) Shravan Dave et al. HEPATOLOGY
- Combined Effect of PNPLA3 , TM6SF2 , and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
- (2020) Helene Gellert-Kristensen et al. HEPATOLOGY
- A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma
- (2020) Matteo Serenari et al. JOURNAL OF HEPATOLOGY
- Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
- (2020) Nalee Kim et al. JOURNAL OF HEPATOLOGY
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
- (2020) Johann von Felden et al. ONCOGENE
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
- (2020) Andrew X Zhu et al. ESMO Open
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- Comparison of anatomic and non-anatomic resections for very early-stage hepatocellular carcinoma: The importance of surgical resection margin width in non-anatomic resection
- (2020) Che-Min Su et al. SURGICAL ONCOLOGY-OXFORD
- Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation
- (2019) Nicolas Goldaracena et al. JOURNAL OF HEPATOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) A Vogel et al. ANNALS OF ONCOLOGY
- Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018
- (2019) Yeun-Yoon Kim et al. RADIOLOGY
- Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
- (2019) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
- (2019) Samer Gawrieh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis
- (2019) Giammauro Berardi et al. JOURNAL OF HEPATOLOGY
- First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma
- (2019) Richard D Kim et al. Cancer Discovery
- Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West
- (2019) Hansen Dang et al. HEPATOLOGY
- Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach
- (2019) Guohong Han et al. HEPATOLOGY
- International trends in hepatocellular carcinoma incidence, 1978–2012
- (2019) Jessica L. Petrick et al. INTERNATIONAL JOURNAL OF CANCER
- Inducing and exploiting vulnerabilities for the treatment of liver cancer
- (2019) Cun Wang et al. NATURE
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis
- (2018) Dimitrios Moris et al. EJSO
- Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
- (2018) Riad Salem et al. HEPATOLOGY
- Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
- (2018) Marianne Ziol et al. HEPATOLOGY
- Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
- (2018) Devalkumar J. Rajyaguru et al. JOURNAL OF CLINICAL ONCOLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm
- (2018) Kayvan Mohkam et al. JOURNAL OF HEPATOLOGY
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
- (2018) Antonietta Romano et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
- (2018) Ismail Labgaa et al. ONCOGENE
- Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
- (2018) Roser Pinyol et al. GUT
- Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
- (2018) Antonio Daniele Pinna et al. ANNALS OF SURGERY
- Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
- (2018) JIMMY XU et al. ANTICANCER RESEARCH
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
- (2017) George V. Papatheodoridis et al. HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
- (2017) Oliver John Kennedy et al. BMJ Open
- The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
- (2016) Enze Jiang et al. CANCER LETTERS
- Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial
- (2016) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
- (2016) Karen T. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
- (2016) Daniel R. Wahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma
- (2016) Andrew X. Zhu et al. JOURNAL OF HEPATOLOGY
- Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
- (2016) Jorge A. Marrero et al. JOURNAL OF HEPATOLOGY
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
- (2016) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- Microwave Ablation: Comparison of Simultaneous and Sequential Activation of Multiple Antennas in Liver Model Systems
- (2016) Colin M. Harari et al. RADIOLOGY
- Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
- (2016) Pei-Pei Song WORLD JOURNAL OF GASTROENTEROLOGY
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
- (2016) Masatoshi Kudo et al. Liver Cancer
- Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
- (2015) Christian Toso et al. HEPATOLOGY
- Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis
- (2015) Annalisa Berzigotti et al. HEPATOLOGY
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
- (2015) Luca Viganò et al. JOURNAL OF HEPATOLOGY
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
- (2015) Bruno Vincenzi et al. PLoS One
- Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
- (2014) F. Turati et al. ANNALS OF ONCOLOGY
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Randomized Trial of [131I] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
- (2014) Huijie Bian et al. JNCI-Journal of the National Cancer Institute
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
- (2013) T Meyer et al. BRITISH JOURNAL OF CANCER
- GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
- (2013) R. Lencioni et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
- (2013) Chun-Ju Chiang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Association Between Metabolic Syndrome and Hepatocellular Carcinoma
- (2013) Raxitkumar Jinjuvadia et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
- (2013) Jianhua Yin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
- (2012) Yan Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
- (2012) Silvia Tremosini et al. GUT
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma
- (2011) Gia L. Tyson et al. Clinical Gastroenterology and Hepatology
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times
- (2011) Khairuddin Memon et al. GASTROENTEROLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
- (2008) Luca Di Tommaso et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now